Life sciences and patient organization deal value
Estimated total aggregate value of publicly announced deals between patient organizations and life sciences companies.
Unit billion USD Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Life sciences and patient organization deal value
United States, as of 5 Oct 2023
Every record
All records
1 record · 1 region · 2008–2023
| Period | Value | Source | Type |
|---|---|---|---|
| United States 1 record | |||
| as of 5 Oct 2023 | 2.4 billion USD | IQVIA · 5 Oct 2023 | estimate |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Supporting patients through research collaboration | IQVIA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Life sciences and patient organization deal value. Retrieved from https://statorigin.org/indicators/life-sciences-and-patient-organization-deal-value